Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
Sipai Health (00314.HK) Sells Pharmacy Business for Gain of RMB49.14 million
Recommend 1 Positive 2 Negative 0 |
||||
|
||||
|
Sipai Health (00314.HK) announced that it has disposed of a 100% equity interest in Sipai Zhihe Technology to an independent third party, Dashenlin Pharmaceutical Group (603233.SH). The target company currently operates four pharmacies in Beijing and Hubei Province, and also runs a supply chain business providing services to pharmacies nationwide. The cash consideration for the transaction is RMB51.73 million. The estimated gain on disposal is approximately RMB49.14 million. (de/d) This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. Auto-translated by AI AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
